ARCHIVES

Penn Begins Clinical Trial Of A Vaccine For Breast Cancer Based On Telomerase

This article is from The Cancer Letter archive.

Vol. 27 No. 2 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

Genetics Flexes Muscle At AACR Annual Meeting, Joint Session With ASCO On Genetic Charges

May 24, 1991

DCE Reorganization Planned To Stem Departures, Stabilize

March 24, 1995

OSCC Groups Send Four Concepts To NCI Board

September 13, 1985

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

DeVita Considers Laetrile Tests

June 3, 1977